Martin Soubrier

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

M.J. Peters, Deborah Symmons, David McCarey et al. · Annals of the Rheumatic Diseases · 2009 · 1.3K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

Maxime Dougados, Martin Soubrier, Anna Antunez et al. · Annals of the Rheumatic Diseases · 2013 · 858 citations · Full text

Medicine, Genetics, Molecular Genetics +14

A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis

Gary S. Hoffman, María C. Cid, David B. Hellmann et al. · Arthritis & Rheumatism · 2002 · 576 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +13

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein et al. · New England Journal of Medicine · 2018 · 502 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

Benjamin Terrier, Zahir Amoura, Philippe Ravaud et al. · Arthritis & Rheumatism · 2010 · 410 citations

Life Sciences, Immunology, Pharmacotherapy +13